EUnetHTA 2020 Forum – Registration Now Open!
We are pleased to announce that registration is now open for the EUnetHTA 2020 Forum, held this year on 2nd April at Zorginstituut Nederland (ZIN), the Dutch Health Care Institute, in Diemen near Amsterdam. We will, once more, provide a Forum
EUnetHTA releases the second version of its methodological guideline “Process of information retrieval for systematic reviews and health technology assessments on clinical effectiveness”
The aim of this methodological guideline is to provide an up-to-date and transparent overview of the whole information retrieval process for Systematic reviews and HTAs on clinical effectiveness. In particular, the requirements presented in this methodological guideline aim to provide orientation
OTCA24 – Final Project Plan and related documentation now available.
EUnetHTA is pleased to announce that the final project plan and related documents from external experts for the Other Technologies Collaborative Assessment OTCA24 “The 24-hour blood pressure measurement device Mobil-O-Graph® with the built-in pulse wave velocity algorithm ARCSolver® to measure
Important Event Dates – 2020/21
We would like to confirm some dates for key EUnetHTA events throughout the remainder of JA3. Please ensure to put these in your agenda: 25-26 March, 2020 - Heads of Agencies Meeting (Spring 2020) 1-2 April, 2020 - EUnetHTA Assembly & Forum 2020 29-30 October, 2020 - Heads
PTJA09 – ‘Brolucizumab for the treatment of adults with neovascular (wet) age-related macular degeneration (AMD)’ project plan now available
The final project plan of the relative effectiveness of ‘Brolucizumab for the treatment of adults with neovascular (wet) age-related macular degeneration (AMD)' is now available for access. The final assessment report will be published on 12th March, 2020. Below is the documentation
OTCA22 – Final Assessment Report and related documents now available
The final assessment report and related documents for the Other Technologies Collaborative Assessment 'Point-of-care Tests (POCT): D-Dimer and Troponin' are now available for access. Troponin and D-dimer point of care tests can be used to aid the diagnosis of patients with
November 2019 Implementation Report – Now Available
EUnetHTA is pleased to announce the new Implementation Report with Appendices are now available for access. The report covers the updated use and uptake on all Joint Action 3 assessments. The report and all related documentation is available at this link, or
PTJA06 – “Polatuzumab vedotin in combination with bendamustine and rituximab for the treatment of relapsed/refractory diffuse large B-cell lymphoma (DLBCL)” final project plan now available.
The final project plan of the assessment on polatuzumab is now available. The final assessment report will be published on 13th February, 2020. Please access the final project plan at the following link: PTJA06 Final Project Plan
OTCA17 – Final Assessment Report and related documents now available
The final assessment report and related documents for the Other Technologies Collaborative Assessment 'Lithium triborate (LBO) laser for photoselective vaporisation of the prostate (PVP) in the treatment of benign prostatic hyperplasia (BPH)' are now available for access. The present assessment addressed
OTCA23 Final Project Plan and related documents now available
EUnetHTA is pleased to announce that the final project plan and related documents from external experts for the Other Technologies Collaborative Assessment OTCA23 "Biodegradable rectum spacers to reduce toxicity for prostate cancer'' are now available for access. The final assessment report